GWC facilitates a $40m investment in Sphere Fluidics

GWC is please to announce, that together with Peel Hunt, it ran a process to introduce portfolio company Sphere Fluidics to suitable global health care funds which has resulted in significant growth funding. The round was led by Sofinnova Partners (Paris, France) and Redmile Group (San Francisco, USA) co-investing on equal terms.

Sphere Fluidics will use the funding to enable the expansion of the Company’s international sales activities in key markets and improving its support for customers. Furthermore, it will expand its product research and development programs, including novel applications for its proprietary Cyto-Mine® Single Cell Analysis System.

Frank Craig, CEO, Sphere Fluidics, commented: “This funding round is not only testament to the potential of Sphere Fluidics’ single cell analysis technology, but also to the expertise of our team. The investment will underpin our growth strategy, enabling us to expand both our product range and our support to new and existing customers, globally.

Ian Leigh, Founder, Greenwood Way Capital, commented: “We are very pleased to welcome Sofinnova and Redmile as fellow shareholders and look forward to working with them. This event highlights the potential and the value of many early stage UK companies with world leading technology.”

Full Press Release.

GWC is a network of UHNWIs and Family Offices that invest in early stage UK companies that have disruptive technology. For further information see http://www.gwcinvestor.com


GWC facilitates a $40m investment in Sphere Fluidics

GWC facilitates a $40m investment in Sphere Fluidics

By Greenwood Way Capital08 Nov 2021